TR200000808T2 - Triscyklik triyazolobenzazepin türevler, bunları üretme süreci ve anti alerjik. - Google Patents

Triscyklik triyazolobenzazepin türevler, bunları üretme süreci ve anti alerjik.

Info

Publication number
TR200000808T2
TR200000808T2 TR2000/00808T TR200000808T TR200000808T2 TR 200000808 T2 TR200000808 T2 TR 200000808T2 TR 2000/00808 T TR2000/00808 T TR 2000/00808T TR 200000808 T TR200000808 T TR 200000808T TR 200000808 T2 TR200000808 T2 TR 200000808T2
Authority
TR
Turkey
Prior art keywords
triyazolobenzazepine
derivatives
triscyklik
producing
anti allergic
Prior art date
Application number
TR2000/00808T
Other languages
English (en)
Inventor
Ohtsuka Yasuo
Nishizuka Toshio
Shiokawa Sohjiro
Tsutsumi Seiji
Kawaguchi Mami
Kitagawa Hideo
Takata Hiromi
Shishikura Takashi
Ishikura Toyoaki
Fushihara Kenichi
Okada Yumiko
Miyamoto Sachiko
Shiobara Maki
Original Assignee
Meiji Seika Kaisha, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha, Ltd. filed Critical Meiji Seika Kaisha, Ltd.
Publication of TR200000808T2 publication Critical patent/TR200000808T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Bir ön ilaç biçiminde , trisiklik triyazolobenzazepin türevleri saglanmistir. Bu bulusa uygun bilesikler, asagidaki formül (I) ile temsil edilen bilesikler ve bunlarin, farmakolojik bakimdan uygun tuzlari ve solvatlaridir. Bu bulusun bilesikleri, antialerjik etkenler olarak yaralidir ve mükemmel biyolojik yararlilik göstermektedir. Formül (I).
TR2000/00808T 1997-09-29 1998-09-29 Triscyklik triyazolobenzazepin türevler, bunları üretme süreci ve anti alerjik. TR200000808T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26461197 1997-09-29
JP5206398 1998-03-04

Publications (1)

Publication Number Publication Date
TR200000808T2 true TR200000808T2 (tr) 2000-08-21

Family

ID=26392670

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00808T TR200000808T2 (tr) 1997-09-29 1998-09-29 Triscyklik triyazolobenzazepin türevler, bunları üretme süreci ve anti alerjik.

Country Status (24)

Country Link
US (3) US6372735B1 (tr)
EP (1) EP1026167B1 (tr)
JP (1) JP3188482B2 (tr)
KR (1) KR100389140B1 (tr)
CN (2) CN1312135C (tr)
AT (1) ATE233764T1 (tr)
AU (1) AU744636B2 (tr)
BR (1) BR9814055B1 (tr)
CA (1) CA2305307C (tr)
DE (1) DE69811930T2 (tr)
DK (1) DK1026167T3 (tr)
ES (1) ES2191963T3 (tr)
HU (1) HUP0004020A3 (tr)
ID (1) ID24101A (tr)
IL (1) IL135303A0 (tr)
NO (2) NO319542B1 (tr)
NZ (1) NZ503601A (tr)
PL (1) PL339544A1 (tr)
PT (1) PT1026167E (tr)
RU (1) RU2198885C2 (tr)
SK (1) SK283869B6 (tr)
TR (1) TR200000808T2 (tr)
TW (1) TW510902B (tr)
WO (1) WO1999016770A1 (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2346858T3 (es) * 2001-12-26 2010-10-21 Meiji Seika Kaisha Ltd. Sustancia amorfa de un derivado triciclico de triazolobenzazepina.
ATE359277T1 (de) 2002-02-01 2007-05-15 Meiji Seika Kaisha Verfahren zur herstellung einer 1,2,3- triazolverbindung
ATE543497T1 (de) 2002-07-09 2012-02-15 Bristol Myers Squibb Co Substituierte heterozyklische derivate als mittel gegen diabetes und adipositas und verfahren
AU2003259131A1 (en) 2002-07-09 2004-01-23 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
JPWO2004113343A1 (ja) * 2003-06-19 2006-08-31 明治製菓株式会社 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
JPWO2004113451A1 (ja) * 2003-06-20 2006-08-17 明治製菓株式会社 難溶性物質と水溶性高分子との共沈物およびその製造方法
ATE381566T1 (de) 2004-05-14 2008-01-15 Millennium Pharm Inc Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
WO2007100079A1 (ja) 2006-03-02 2007-09-07 Meiji Seika Kaisha, Ltd. 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤
US8242105B2 (en) * 2006-09-25 2012-08-14 Forschungsverbund Berlin E.V. Structural mimetics of proline-rich peptides and the pharmaceutical use thereof
CL2007003244A1 (es) * 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
DE602008004820D1 (de) * 2007-12-18 2011-03-17 Meiji Seika Kaisha Vorbeuge- oder heilmittel für entzündliche darmerkrankungen
ES2468391T3 (es) 2008-12-22 2014-06-16 Millennium Pharmaceuticals, Inc. Combinación de inhibidores de cinasas Aurora y anticuerpos anti-CD20
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
ES2768295T3 (es) * 2010-01-07 2020-06-22 Alkermes Pharma Ireland Ltd Profármacos de compuestos heteroaromáticos
JP2013520424A (ja) 2010-02-19 2013-06-06 ミレニアム ファーマシューティカルズ, インコーポレイテッド ナトリウム4−{[9−クロロ−7−(2−フルオロ−6−メトキシフェニル)−5H−ピリミド[5,4−d][2]ベンゾアゼピン−2−イル]アミノ}−2−メトキシベンゾエートの結晶形
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
WO2017015316A1 (en) 2015-07-21 2017-01-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
AR114070A1 (es) * 2017-12-29 2020-07-15 Biomarin Pharm Inc Inhibidores de glicolato oxidasa para el tratamiento de una enfermedad

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69411243T2 (de) 1993-04-16 1998-11-19 Shionogi & Co Verfahren zur herstellung eines lignan-derivats
ES2156933T3 (es) 1993-12-28 2001-08-01 Meiji Seika Co Derivados triciclicos de benzazepina y benzotiazepina.
JP3537446B2 (ja) * 1995-06-15 2004-06-14 明治製菓株式会社 三環性ベンゾアゼピン化合物
NZ330973A (en) * 1996-03-08 2000-03-27 Zeneca Ltd Azolobenzazepine derivatives as neurologically active agents
US20070059533A1 (en) * 2005-09-12 2007-03-15 Burdette Steven R Thermal reflow of glass and fused silica body

Also Published As

Publication number Publication date
WO1999016770A1 (en) 1999-04-08
ES2191963T3 (es) 2003-09-16
NO319542B1 (no) 2005-08-29
KR20010030784A (ko) 2001-04-16
IL135303A0 (en) 2001-05-20
TW510902B (en) 2002-11-21
EP1026167A4 (en) 2001-07-11
CA2305307A1 (en) 1999-04-08
KR100389140B1 (ko) 2003-06-25
US20020137739A1 (en) 2002-09-26
AU744636B2 (en) 2002-02-28
PT1026167E (pt) 2003-07-31
US7238812B2 (en) 2007-07-03
JP3188482B2 (ja) 2001-07-16
NO20043765L (no) 2000-05-18
CN1523019A (zh) 2004-08-25
NO20001500L (no) 2000-05-18
HUP0004020A2 (hu) 2001-09-28
BR9814055A (pt) 2000-09-26
HK1032782A1 (en) 2002-08-30
CN1278262A (zh) 2000-12-27
ID24101A (id) 2000-07-06
ATE233764T1 (de) 2003-03-15
EP1026167A1 (en) 2000-08-09
CN1155599C (zh) 2004-06-30
CN1312135C (zh) 2007-04-25
RU2198885C2 (ru) 2003-02-20
CA2305307C (en) 2004-11-30
BR9814055B1 (pt) 2009-05-05
US20060074074A1 (en) 2006-04-06
US6372735B1 (en) 2002-04-16
PL339544A1 (en) 2000-12-18
US7022860B2 (en) 2006-04-04
DE69811930T2 (de) 2003-12-18
SK4252000A3 (en) 2000-10-09
EP1026167B1 (en) 2003-03-05
HUP0004020A3 (en) 2002-12-28
NO20001500D0 (no) 2000-03-23
DK1026167T3 (da) 2003-05-26
AU9186998A (en) 1999-04-23
SK283869B6 (sk) 2004-03-02
NZ503601A (en) 2002-02-01
DE69811930D1 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
CY1120189T1 (el) Λιπιδια, συμπλοκα λιπιδιων και χρηση εξ' αυτων
CY1105967T1 (el) Παραγωγα 4,5-διϋδρο-1η-πυραζολιου που εχουν cb1 - ανταγωνιστικη δραστικοτητα
BR9507615A (pt) Composto e processo para produzir um composto
TR199801734T2 (tr) Yeni arilglisinamid türevleri, üretim yöntemleri.
ATE448226T1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
TR199800756T2 (tr) 1-(1,2-disübstitüe piperidinil)-4-sübstitüe piperazin türevleri.
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
BR9805734A (pt) Derivados de imidazolin-4-ona úteis como agentes anticancerìgenos.
CA2280905A1 (en) Highly lipophilic camptothecin derivatives
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
TR200200100T2 (tr) Kristalin 1-metilkarbapenem türevleri.
EA200100422A1 (ru) Производные мононитрата изосорбида и их использование в качестве сосудорасширяющих агентов с пониженной толерантностью
EP1201668A4 (en) Staurosporine DERIVATIVES
DE69813605D1 (de) Benzofuranderivate
PT1026167E (pt) Derivados triciclicos de triazolbenzazepina processo para a sua preparacao e agentes anti-alergicos
ATE296300T1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
ATE236148T1 (de) Synthese der terfenadin und deren derivate
SI1847534T1 (sl) Tiadiazolinski derivati za zdravljenje raka
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
CO5011066A1 (es) Compuestos de triazina
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
TR199900403T2 (tr) Amorf benzotiofenler, hazirlama yöntemleri ve kullanma yöntemleri.
DK1299388T3 (da) Variolin-derivater som anti-cancermidler
ES2122751T3 (es) Composicion antialergica que comprende un compuesto diester fosforico.
AR008616A1 (es) Uso de derivados de fluo-antraciclinona y fluo-antraciclina.